← Back to Clinical Trials
Recruiting NCT05898529

NCT05898529 COVID Infection in Pediatric Surgical Patient

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05898529
Status Recruiting
Phase —
Sponsor Salem Anaesthesia Pain Clinic
Condition COVID-19
Study Type OBSERVATIONAL
Enrollment 350 participants
Start Date 2023-07-01
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 2 Years
Max Age 17 Years
Study Type OBSERVATIONAL
Interventions
Rapid antigen test

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 350 participants in total. It began in 2023-07-01 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Children infected with COVID-19 are mostly asymptomatic. There is a dearth of data on the epidemiology of COVID-19 in the pediatric population. This is a prospective observational clinical study of pediatric surgical patients. COVID-19 rapid antigen testing will be performed on pediatric patients.

Eligibility Criteria

Inclusion Criteria: * surgical patients aged 2-17 years * informed consent for surgery * no COVID-19 diagnosis in previous 6 months * no history of nasal bleeding * no history of coagulopathy. Exclusion Criteria: * patient refusal of testing * difficulty in obtaining consent * COVID-19 diagnosis in recent 6 month * history of nasal bleeding * history of coagulopathy.

Contact & Investigator

Central Contact

Olumuyiwa Bamgbade, MD,FRCPC

✉ olu.bamgbade@gmail.com

📞 17786286600

Principal Investigator

Olumuyiwa Bamgbade

PRINCIPAL INVESTIGATOR

Salem Anaesthesia Pain Clinic

Frequently Asked Questions

Who can join the NCT05898529 clinical trial?

This trial is open to participants of all sexes, aged 2 Years or older, up to 17 Years, studying COVID-19. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05898529 currently recruiting?

Yes, NCT05898529 is actively recruiting participants. Contact the research team at olu.bamgbade@gmail.com for enrollment information.

Where is the NCT05898529 trial being conducted?

This trial is being conducted at Surrey, Canada.

Who is sponsoring the NCT05898529 clinical trial?

NCT05898529 is sponsored by Salem Anaesthesia Pain Clinic. The principal investigator is Olumuyiwa Bamgbade at Salem Anaesthesia Pain Clinic. The trial plans to enroll 350 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology